- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
ZIOPHARM Oncology Inc
+ Add to WatchlistZIOP:US
1.8100 USD 0.0100 0.56%As of 09:56:30 ET on 05/21/2013.
Snapshot for ZIOPHARM Oncology Inc (ZIOP)
| Open: | 1.8000 | Day's Range: | 1.7800 - 1.8300 | Volume: | 155,448 |
|---|---|---|---|---|---|
| Previous Close: | 1.8000 | 52wk Range: | 1.4900 - 6.3300 | 1-Yr Rtn: | -61.73% |
Key Statistics for ZIOP
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -1.0500 |
| Est. EPS (USD) (12/2013) | -0.8670 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 150.41 |
| Shares Outstanding (M) | 83.56 |
| 30 Day Average Volume | 1,008,073 |
| Price/Book (mrq) | 3.9971 |
| Price/Sale (ttm) | 181.7175 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ZIOP
Company Profile & Key Executives for ZIOP
ZIOPHARM Oncology, Inc. is a biopharmaceutical company seeking to acquire, develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs.
| Jonathan J LewisChief Executive Officer | Jason A AmelloExec VP/CFO/Treasurer |
| Caesar J BelbelExec VP/Chief Legal Ofcr/Secy |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ZIOP News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page